Trial · NCT02310919
Outcomes29
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Total Fertilization Proportion (i.e. Total Competent Proportion) | 2 days | ratio | MEAN | |
| SECONDARY | Number of Oocytes Retrieved | 1 day | No outcome data for 1 participant that elected to convert to intrauterine insemination after trigger | oocytes | MEAN |
| SECONDARY | Number of MII Oocytes | 1 day | This parameter can only be calculated in patients that underwent oocyte stripping to undergo intracytoplasmic sperm injection for fertilization method. | MII oocytes | MEAN |
| SECONDARY | Total Oocyte Maturity Rate | 1 day | This parameter can only be calculated in patients that underwent oocyte stripping to undergo intracytoplasmic sperm injection for fertilization method. | ratio of MII oocytes | MEAN |
| SECONDARY | Mature Oocyte Recovery Proportion | 1 day | This parameter can only be calculated in patients that underwent oocyte stripping to undergo intracytoplasmic sperm injection for fertilization method. | ratio | MEAN |
| SECONDARY | ICSI Fertilization Rate | 2 days | This parameter can only be calculated in patients that were undergoing intracytoplasmic sperm injection for fertilization method. One participant the low dose hCG plus FSH co-trigger arm was not included in the analysis as they underwent oocyte cryopreservation instead as the male partner was unable to produce fresh sperm sample to fertilize the oocytes. | ratio of fertilized oocytes | MEAN |
| SECONDARY | High Quality Cleavage-stage Embryos | 4 days | No outcome data for 3 participants: 1) participant that elected to convert to intrauterine insemination after trigger; 2) participant that underwent oocyte cryopreservation due to male partner being unable to produce fresh sperm sample for fertilization; 3) cleavage-stage embryo quality was inadvertently not documented by the staff embryologist in one participant | ratio of good quality embryos | MEAN |
| SECONDARY | High Quality Blastocyst Embryos | 6 days | ratio of good quality embryos | MEAN | |
| SECONDARY | Livebirth Rate From All Fresh Transfers | 10 months | Only patients that underwent a fresh embryo transfer can be included in this analysis. Not all participants underwent fresh embryo transfers. | live births | NUMBER |
| SECONDARY | Bloating Score | about 16 days (varies by subject), accounts for the median length of IVF stimulation in this study being 11 days from baseline to 5 days post trigger | Only patients that answered this question on the study questionnaire could be included in this analysis. | score on a scale | MEDIAN |
| SECONDARY | Abdominal Circumference | about 16 days (varies by subject), accounts for the median length of IVF stimulation in this study being 11 days from baseline to 5 days post trigger | Only patients that had their abdominal circumference measured on both day of baseline ultrasound and post-trigger day 5 could be included in this analysis. | centimeters | MEDIAN |
| SECONDARY | Body Weight | about 16 days (varies by subject), accounts for the median length of IVF stimulation in this study being 11 days from baseline to 5 days post trigger | Only patients that had their body weight measured on both day of baseline ultrasound and post-trigger day 5 could be included in this analysis. | difference in kilograms | MEDIAN |
| SECONDARY | Serum hCG T+1 | 1 day | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | IU/L | MEDIAN |
| SECONDARY | Serum FSH T+1 | 1 day | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | mIU/ml | MEDIAN |
| SECONDARY | Serum P4 on T+1 | 1 day | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | ng/ml | MEDIAN |
| SECONDARY | Serum E2 on T+1 | 1 day | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | pg/ml | MEDIAN |
| SECONDARY | Serum LH on T+1 | 1 day | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | mIU/ml | MEDIAN |
| SECONDARY | Serum hCG on T+2 | 2 days | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | IU/L | MEDIAN |
| SECONDARY | Serum FSH on T+2 | 2 days | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | mIU/ml | MEDIAN |
| SECONDARY | Serum P4 on T+2 | 2 days | Only comparisons to the standard 10,000 IU hCG trigger dose are presented using the per-protocol study population. | ng/ml | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02310919/outcomes